A defensive industrial in one of the few sectors where pricing power genuinely exceeds inflation, with a balance sheet built on assets the regulator essentially refuses to permit any more of. Waste Management is the kind of issuer that does not make for the most exciting equity pitch — and that is precisely what makes the bond interesting. Stable cash flows. Long-dated maturities. A management team in active deleveraging mode after a major acquisition. And a single bond, the WM 1.50% of March 2031, trading at a meaningful discount to par on the back of nothing more dramatic than the rate cycle.

This is a teaching walkthrough of why Investment Team 3 is pitching a corporate bond — what to look at, what to push on, and how the numbers actually fit together.

What we are actually buying

This is not a yield-and-hold bond pitch. The team is using the price-appreciation strategy described in the Bonds session: buy a bond at a discount to par when the macro setup favours falling yields, and sell into the rally before maturity. The 2031 paper is the right instrument for this strategy because the three structural drivers stack the same way — long maturity, low coupon, low yield — which maximises duration and therefore the price upside as rates fall.

The trade is mechanical. Hold the bond for two years, let yields drift lower as the Fed eventually resumes cutting, collect coupon income while the price grinds toward par, exit before duration becomes a liability in the back end of the holding period. No equity risk taken.

The issuer in one frame

Before defending a bond pitch you have to defend the issuer behind it. WM is a defensive industrial with five properties worth holding in mind as you read the rest:

What WM actually does

WM operates a vertically integrated waste platform: it wins contracts, picks up the waste, transfers it through 342 stations to be compacted, disposes or diverts it through 253 landfills, 113 recycling sites, 49 organics sites and the Stericycle medical-waste network, extracts energy from landfill gas via 103 RNG and electricity projects, and books the revenue as service fees plus tipping fees plus commodity sales plus RIN/REC credits. The integration is the moat. Every fee that would otherwise leak to a third party stays in-house.

Revenue: predictable and growing

FY2021–FY2025. ~8.9% CAGR. Source: WM FY2025 Report.

The growth is the product of two compounding factors: contractual price escalators that consistently outpace inflation (FY2024 saw 6.7% core price growth), plus volume expansion through tuck-in M&A. The 2024–2025 jump is structurally important — Stericycle adds Healthcare Solutions as a new 10%-of-revenue line, broadening the diversification base.

Why a bond — and why this bond?

The WM equity is a perfectly reasonable long-only defensive holding. So the relevant question is: what does the bond give us that the equity does not? Three things.

The instrument-specific case is laid out below; it draws on the credit-scoring framework that Quant introduced in the Bonds session.

Walking through the credit

The PMC Credit Scoring Model breaks issuer creditworthiness into seven weighted layers. Every credit pitch should defend each layer with numbers, not just narrative. Here is how WM lands.

Capital structure

Total debt is roughly 21% of total capitalisation — a substantial equity cushion sits beneath bondholders. 95% of total debt is long-term, with maturities concentrated beyond 2030 (50% of total debt). Near-term refinancing pressure is low.

The 2024 spike in long-term debt is the Stericycle financing. Source: Bloomberg, 10-K.

Liquidity

Below industry-average ratios, but not the right read on whether the company can actually pay its bills.

WM's PMC liquidity score (8.9 / 100) is the weakest layer of the credit, but it sits within the industry norm. Republic Services, Waste Connections, and GFL all show similar patterns. The score weight in the model is only 10% — and rightly so.

Coverage

The Interest Coverage Ratio fell from 8.3× to 5.2× over the period — but that is the Stericycle deal showing up in the numerator (more interest expense on financing debt) and the denominator (EBIT growing more slowly than the debt step). EBIT itself grew from $3.0bn to$4.7bn, so the deterioration is structural, not operational. OCF / Debt rebounded to 25% in 2025 with operating cash flow climbing from $4.3bn to$6.0bn. The PMC coverage score (76.4 / 100) is comfortably above the peer mean.

Profitability and turnover

This is where WM separates from its peer group and earns its A- rating.

Margins expanded steadily through the period despite multiple acquisitions. Source: Bloomberg.

Gross margin has expanded every single year, driven by disciplined CPI+ pricing and route automation. ROIC sits at 10.1% in 2025 — above the peer median, despite the Stericycle goodwill drag. WM's PMC profitability score is 100 / 100: the highest in the peer set. ROE compression in 2025 is mathematical (equity base diluted by the acquisition), not a deterioration in earnings quality.

Leverage

The Stericycle acquisition pushed every leverage ratio up in 2024. Every single one came down in 2025. Management explicitly suspended the buyback programme to prioritise debt repayment, and the deleveraging is showing through in the numbers. Fitch cited $1bn+ of debt paydown since the Stericycle close when reaffirming A- with a Stable outlook in February 2026.

Debt governance

This is the strongest layer of the entire credit, and the layer that most separates A-rated industrial issuers from speculative-grade ones.

Near-term annual maturities (2026–2034) range from ~$450M to ~$2.1B per year, with no single year representing an unmanageable refinancing cliff. Over 55% of total corporate debt matures in 2035 or later — a long-dated maturity tail that takes refinancing pressure off the management agenda for most of the coming decade.

Final credit output

WM lands in the top tier of the PMC peer set on the aggregate credit score, behind only Republic Services and Clean Harbors. The A- rating is fully consistent with the layer-by-layer analysis — the credit is high-quality, with one acknowledged soft spot (liquidity) that the industry structurally tolerates and the model correctly under-weights.

The bond — WM 1.50% 03/2031

The issuer thesis is the foundation. The bond thesis is what we are actually trading.

Why this specific CUSIP

The 2031 paper has the right shape for the strategy: long-enough maturity to carry meaningful duration (4.70 Macaulay) plus enough convexity (0.239) to give the position positive asymmetry, but not so long that it becomes pure interest-rate beta. It also wins on bond-level analytics:

• Attractive OAS for an A-rated issuer — the spread compensation is wider than peer bonds at comparable ratings.
• Highest liquidity score among peer bonds in the screen — important for entry and exit discipline at a 4% allocation.
• Lowest beta in the comparable set (0.41) and moderate 260-day volatility — supports a predictable pull-to-par trajectory.
• Positive Sharpe ratio on the historical track record — the bond has actually delivered risk-adjusted return, not just yield.

Two-year horizon, not buy-to-maturity

The team is explicit on this point. We exit before maturity for two reasons.

Catalysts and risks

The honest version. The catalysts are mostly built into the issuer mechanics; the risks are mostly external — macro and operational.

Catalysts

Risks

The macro backdrop

The recommendation does not depend on Fed cuts, but Fed cuts are upside. The CME FedWatch implied probability for the next FOMC meeting sits at ~96.8% no-change — markets are pricing the pause into the curve. Any rate cut during the two-year horizon translates directly into bond price upside through duration. The structural thesis is intact even in a flat-rates scenario; the cut just accelerates the pull-to-par.

The trade structure

A clean execution plan rather than a recommendation paragraph.

The dynamic TP/SL design is deliberate. Static price targets at entry assume a static yield environment for two years — which is not what the trade is taking a view on. Letting the model recalibrate as rates and credit spreads move means the stops protect the strategy, not an arbitrary price level.

Recommendation: BUY — 4% allocation, 2-year horizon, dynamic TP/SL.